Skip to main content
Google Tag Manager
P&T COMMUNITY
Register
Sign in
Search form
Search
News
Approvals, Launches, & New Indications
Pipeline Plus
Research News
Industry Trends
Safety Issues
Agency Actions
Health Care Reform
Guidelines
Clinical Trials
P&T
Current issue
Past issues
Contact us
Digital Edition
Subscribe
P&T TV
Dr. David B. Nash
Meeting Reports
Health Care & Law
Drug Forecast
More
Meeting Highlights
Medication Errors
Prescription: Washington
Authors
About
Contact Us
News
P&T Journal
Formulary Kits
INGREZZA®
(valbenazine) tablets
JAKAFI®
ruxolitinib (tablets)
KEDRAB™
(Rabies Immune Globulin [Human])
LOKELMA™
(sodium zirconium cyclosilicate) 10 g for oral suspension
PERSERIS™
(risperidone) for extended-release injectable suspension
ZULRESSO™
(brexanolone) injection CIV
You are here
Home
News by month %2 2009
News by month October 2009
PTCommunity News October 2009
Fluarix Receives Pediatric Use Indication
Two High Blood Pressure Medicines Show Promise for Treating Heart Disease
Angiogenesis Inhibitor Pazopanib Approved to Treat Advanced Renal Cell Carcinoma
FDA Approves New Indication for Gardasil to Prevent Genital Warts in Men and Boys
FDA Approves New Vaccine for Prevention of Cervical Cancer
Affordable Anti-rejection Drug As Effective As Higher Cost Option
Comparative Effectiveness Grant Awarded to Study Angioplasty and Surgery
National Cancer Network Updates Cervical Cancer Screening Guidelines
Fentanyl Buccal Film Now Available for the Management of Breakthrough Pain in Cancer
Study Suggests Mastectomy Not Being Overused for Breast Cancer Treatment
FDA Requires Randomized, Controlled Study Before Approving Clofarabine for Adults With Acute Myeloid Leukemia
FDA's Oncologic Panel Recommends to Approve Pazopanib for Patients With Advanced Renal Cell Carcinoma
